EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Hepatocyte Nuclear Factor 4 Alpha: A Key Regulator of Liver Disease Pathology and Haemostatic Disorders

Subhadip Choudhuri iD, Nisha Jain Garg

Liver International · 2025

DOI: 10.1111/liv.16245 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Liver International, 2025. Verfasst von Subhadip Choudhuri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Texas Medical Branch (UTMB), Galveston, Texas, USA. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 4, Liver Diseases, Hemostatic Disorders. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH/NIAID (AI178318), IHII/UTMB.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Hepatocyte nuclear factor 4 alpha (HNF4α) is a master regulator of hepatocyte differentiation in fetal and adult liver and exerts its transcriptional role in determining physiological functions of the liver. The objective of this review is to address the current knowledge of molecular mechanisms involved in HNF4α regulation in multiple aspects of liver disease pathogenesis.

Methods

Based on available literature, this review summarises the current state of knowledge onthe mechanism of HNF4α dysregulation, and the role of HNF4α activity inregulating early to advanced stages of various liver diseases.

Results

Patients with deranged HNF4α expression are at higher risk for the development of liver diseases such as viral hepatitis, alcoholic/nonalcoholic fatty liver disease, hepatocellular carcinoma, and haematological disorders such as coagulopathy and bleeding disorders.

Discussion

HNF4α interactions with nuclear receptors and target genes promote liver disease pathology by regulating various metabolic pathways. The strong correlation between deranged HNF4α expression and the severity of liver diseases suggests that targeting HNF4α expression can offer potential therapeutic strategy in the prevention of liver disease pathology and haemostatic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatocyte Nuclear Factor 4Liver DiseasesHemostatic DisordersHumansLiverLiver NeoplasmsCarcinoma, HepatocellularAnimalsGene Expression Regulation

Stichwörter der Autor:innen

HNF4αhemostatic and blood disorderliver diseasetranscriptional regulation

Substanzen

Hepatocyte Nuclear Factor 4HNF4A protein, human

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of Texas Medical Branch (UTMB), Galveston, Texas, USA.
  • Institute for Human Infections and Immunity (IHII), University of Texas Medical Branch (UTMB), Galveston, Texas, USA.

ORCID-Profile: Subhadip Choudhuri

Förderung

  • NIAID NIH HHS
  • NIH/NIAID (AI178318)
  • IHII/UTMB
  • University of Texas Medical Branch

Zitieren

APA

Choudhuri, S., & Garg, N. J. (2025). Hepatocyte Nuclear Factor 4 Alpha: A Key Regulator of Liver Disease Pathology and Haemostatic Disorders. Liver International. https://doi.org/10.1111/liv.16245

Vancouver

Choudhuri S, Garg NJ. Hepatocyte Nuclear Factor 4 Alpha: A Key Regulator of Liver Disease Pathology and Haemostatic Disorders. Liver International. 2025. doi:10.1111/liv.16245

BibTeX
@article{Choudhuri2025,
  author = {Choudhuri, Subhadip and Garg, Nisha Jain},
  title = {Hepatocyte Nuclear Factor 4 Alpha: A Key Regulator of Liver Disease Pathology and Haemostatic Disorders},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.16245}
}
Kostenlos starten →